| Literature DB >> 24656615 |
Joy Wolfram1, Yong Yang2, Jianliang Shen3, Asad Moten4, Chunying Chen5, Haifa Shen6, Mauro Ferrari7, Yuliang Zhao8.
Abstract
The interactions between nanoparticles and macromolecules in the blood plasma dictate the biocompatibility and efficacy of nanotherapeutics. Accordingly, the properties of nanoparticles and endogenous biomolecules change at the nano-plasma interface. Here, we review the implications of such changes including toxicity, immunological recognition, molecular targeting, biodistribution, intracellular uptake, and drug release. Although this interface poses several challenges for nanomedicine, it also presents opportunities for exploiting nanoparticle-protein interactions.Entities:
Keywords: Nano-bio interface; Nanoparticles; Plasma; Protein corona; Proteins
Mesh:
Substances:
Year: 2014 PMID: 24656615 PMCID: PMC4152388 DOI: 10.1016/j.colsurfb.2014.02.035
Source DB: PubMed Journal: Colloids Surf B Biointerfaces ISSN: 0927-7765 Impact factor: 5.268